Topics
- The newest pain management practices/methods
- Current novel pain drug candidates and the top trends in pain research and drug formulation, including abuse-resistant technology
- How strategic partnerships and drug repurposing can increase the efficiency of the pain drug development process
- The most recent FDA regulations and initiatives regarding opioids
- How data analytics can improve all levels of the distribution channel, including market access
Who should Attend
Pharma, biotech, med device, and healthcare professionals involved or interested in:
- Abuse / Deterrent / Deterrence / Resistant / Resistance / Abuse deterrent / Abuse Deterrence
- Pain / Pain Medicine / Pain Management
- Addiction / Addiction Treatment / Addiction Medicine
- Abuse / Drug Abuse
- Drug Safety
- Cannabis / Cannabinoid
- Toxicology
- Risk Management / REMS
- Diversion
- Behavioral Psychiatry / Behavioral Health
- Pharmaceutical Development
- Formulations
- Clinical Development
- Preclinical Development
- Policy
- Clinical Development / Operations / Affairs / Programs
- Scientific Affairs
- Regulatory Affairs
- Legal Affairs / Legal Counsel
- Medical Affairs
- Marketing
- Market Access
- Pharmacovigilance
- Pharmacology / Clinical Pharmacology / Safety Pharmacology
- Analytical Development
- Pharmacy
- Neurobiology / Neurology
- Anesthesiology
- Commercial Affairs
- CNS / Neuroscience
- Palliative Care
- Managed Care
- Education
- Pharmacoeconomics / Health Economics / Outcomes Research / HEOR
- Quality
- Informatics
- Epidemiology / Pharmacoepidemiology
- R&D
Also:
- CROs
- Abuse Liability Service Providers
- Formulation Service Providers
- Drug Abuse Registry / Surveillance Specialists
- Law Firms
- Intellectual Property Service Providers
- Regulatory Specialists
- Pharmacokinetics Service Providers
- Toxicology Specialists
- REMS / Pharmacovigilance Specialists
- University Professors Researching Pain / Addiction / Cannabinoids
